SMS Pharmaceuticals
SMSPHARMANSE

SMS Pharmaceuticals

₹383.454.25 (1.12%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
376.55
Today’s high
389.70
52 week low
207.70
52 week high
447.80
Open price
383.00
Previous close
379.20
Live volume
1,28,095
Lower circuit
306.80
Upper circuit
460.10

Fundamentals

Market Cap
₹3,557Cr
ROE
12.98%
P/E Ratio(TTM)
34.88
EPS(TTM)
10.89
P/B Ratio
4.53
Dividend Yield
0.11%
Industry P/E
33.71
Book Value
83.91
Debt to Equity
0.46
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹241
+12.29%
Profit (Cr)
₹20.96
-9.62%
075150225300
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-4%
3Y CAGR+15%
Profit growthValue
1Y (TTM)+4%
3Y CAGR0%

About

Since its inception in 1989, SMS Pharma has embarked on a journey of remarkable growth and innovation, becoming a leader in multiple therapeutic segments. The company's vision is centered on being a quality-conscious organization, focusing on delivering the best value to its customers in the most economical way possible. Its mission involves setting industry benchmarks by developing cost-effective manufacturing processes for Active Pharmaceutical Ingredients (APIs) and marketing them in regulated markets. Leveraging advanced facilities and strong API manufacturing capabilities, the company consistently creates reliable and effective pharmaceuticals to meet evolving market demands. The company maintains a strong global footprint with a strategic presence across 75 countries, which supports its sustainable growth and reduces reliance on imports. In fiscal year 2024, the company achieved an impressive 36% revenue increase to ₹709 crore, driven by robust performance across all its therapeutic areas.;
CEO/MD
Sri. Ramesh Babu Potluri
Founded in
1987
NSE symbol
SMSPHARMA

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
68.07%
Retail And Others
28.60%
Mutual Funds
2.96%
Foreign Institutions
0.31%
Other Domestic Institutions
0.07%

Mutual Funds Invested (1)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹4,509.20
-63.70 (1.39%)
L
    H
    20,918.3828.954.98
    ₹8,249.50
    +21.00 (0.26%)
    L
      H
      20,622.00109.9723.63
      ₹1,404.60
      +39.00 (2.86%)
      L
        H
        18,938.6829.254.85
        ₹766.45
        +3.30 (0.43%)
        L
          H
          18,910.6231.783.72
          Livesquawk
          SMS Pharma Q4 EBITDA fell to ₹399M from ₹413M YoY. Q4 EBITDA margin remained flat at 16.7% YoY.
          Livesquawk
          SMS Pharmaceuticals' Q3 EBITDA rose to 438M INR from 333M INR YOY. EBITDA margin improved to 20.8% in Q3 from 19.2% YOY.
          2026
          22
          May
          Quarterly & Annual Result
          Release date
          7
          Feb
          Quarterly Result
          Release date
          2025
          8
          Nov
          Quarterly Result
          Release date

          22
          Sep
          Dividend
          Ex date
          ₹0.40
          per share

          For each share you hold, you will receive ₹0.40
          Dividend amount₹0.40 per share
          Dividend TypeFinal
          Ex Date22 Sep ‘25
          Record Date22 Sep ‘25
          Announcement date30 May ‘25
          9
          Aug
          Quarterly Result
          Release date

          30
          May
          Dividend
          Announced
          ₹0.40
          per share

          For each share you hold, you will receive ₹0.40
          Dividend amount₹0.40 per share
          Dividend TypeFinal
          Ex Date22 Sep ‘25
          Record Date22 Sep ‘25
          Announcement date30 May ‘25
          2024

          23
          Sep
          Dividend
          Ex date
          ₹0.40
          per share

          For each share you hold, you will receive ₹0.40
          Dividend amount₹0.40 per share
          Dividend TypeFinal
          Ex Date23 Sep ‘24
          Record Date23 Sep ‘24
          Announcement date29 May ‘24
          Events calendar
          View upcoming events in other stocks